1. Home
  2. OP vs EVOK Comparison

OP vs EVOK Comparison

Compare OP & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OP
  • EVOK
  • Stock Information
  • Founded
  • OP 2021
  • EVOK 2007
  • Country
  • OP Greece
  • EVOK United States
  • Employees
  • OP 106
  • EVOK N/A
  • Industry
  • OP
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • OP
  • EVOK Health Care
  • Exchange
  • OP Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • OP 8.3M
  • EVOK 7.1M
  • IPO Year
  • OP N/A
  • EVOK 2013
  • Fundamental
  • Price
  • OP $1.11
  • EVOK $5.37
  • Analyst Decision
  • OP
  • EVOK
  • Analyst Count
  • OP 0
  • EVOK 0
  • Target Price
  • OP N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • OP 11.3K
  • EVOK 9.0K
  • Earning Date
  • OP 04-10-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • OP N/A
  • EVOK N/A
  • EPS Growth
  • OP N/A
  • EVOK N/A
  • EPS
  • OP N/A
  • EVOK N/A
  • Revenue
  • OP $25,729,000.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • OP N/A
  • EVOK $97.35
  • Revenue Next Year
  • OP N/A
  • EVOK $99.52
  • P/E Ratio
  • OP N/A
  • EVOK N/A
  • Revenue Growth
  • OP 36.33
  • EVOK 100.35
  • 52 Week Low
  • OP $1.02
  • EVOK $3.54
  • 52 Week High
  • OP $3.15
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • OP 39.14
  • EVOK 65.36
  • Support Level
  • OP $1.11
  • EVOK $4.68
  • Resistance Level
  • OP $1.18
  • EVOK $5.40
  • Average True Range (ATR)
  • OP 0.04
  • EVOK 0.33
  • MACD
  • OP 0.00
  • EVOK 0.07
  • Stochastic Oscillator
  • OP 3.50
  • EVOK 97.46

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: